Oral GLP-1: A New Era, Market Ready?
Hey everyone, Sarah Miller here! It feels like just yesterday we were all marveling at the advancements in GLP-1 drugs for weight management, and now, we’re seeing the oral versions hitting the market. As a financial analyst with over a decade spent digging into market research and spotting trends, I’ve been watching this development with a keen eye. It’s not just about the medical breakthrough; it’s about the ripple effect it’s having – or should be having – across various sectors, especially in the credit markets. ...